Adium Pharma S.A.
Adium Pharma S.A., a prominent player in the pharmaceutical industry, is headquartered in Uruguay (UY) and operates extensively across Latin America. Founded in 2006, the company has established itself as a leader in the development and manufacturing of high-quality generic and specialty pharmaceuticals. Adium Pharma is renowned for its innovative approach to drug formulation, particularly in the areas of oncology, infectious diseases, and central nervous system disorders. The company’s commitment to quality and compliance has earned it a strong market position, with notable achievements in regulatory approvals and product launches. With a focus on enhancing patient outcomes, Adium Pharma continues to expand its portfolio, offering unique solutions that address unmet medical needs in the region.
DitchCarbon Score
How does Adium Pharma S.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Retail Trade Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Adium Pharma S.A.'s score of 26 is lower than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Adium Pharma S.A.'s reported carbon emissions
Adium Pharma S.A., headquartered in Uruguay (UY), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or commitments to climate initiatives, such as those outlined by the Science Based Targets initiative (SBTi) or other industry standards. As there are no emissions or reduction initiatives reported, it is unclear how Adium Pharma S.A. is addressing its carbon footprint or contributing to climate action within the pharmaceutical industry. The lack of data may suggest an opportunity for the company to develop and communicate its climate commitments more effectively in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Adium Pharma S.A. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
